GGrantIndex
← Leaderboards

Christopher Martens

University Of Colorado

$3,611,104
Attributed
$3,611,104
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY201725
$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,611,104 · 3

By mechanism

R01$1,532,721 · 1
P20$1,355,061 · 1
K01$723,322 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Alzheimer&Apos

Research focus

Alzheimer&AposArterial StiffnessArteriesBlood VesselsMemory LossS DiseaseAortaLinkBrainCarotid ArteriesNeuronsS Disease RiskAge RelatedMemoryMiddle AgeTransmission ProcessAge-Associated Memory ImpairmentMediatingAdultDementiaCerebrovascularAgingImpairmentPathologic

Grant awards (13)

Longitudinal impact of midlife cerebrovascular pulsatility on brain tissue integrity and cognitive aging$764,294
R01 · FY2025 · AG · contact PI
Longitudinal impact of midlife cerebrovascular pulsatility on brain tissue integrity and cognitive aging$768,427
R01 · FY2024 · AG · contact PI
The effects of added sugar intake on brain blood flow and hippocampal function in midlife adults$336,000
P20 · FY2024 · GM · contact PI
The effects of added sugar intake on brain blood flow and hippocampal function in midlife adults$332,594
P20 · FY2023 · GM · contact PI
The effects of added sugar intake on brain blood flow and hippocampal function in midlife adults$341,474
P20 · FY2022 · GM · contact PI
The effects of added sugar intake on brain blood flow and hippocampal function in midlife adults$344,993
P20 · FY2021 · GM · contact PI
NAD+ Therapy for Improving Memory & Cerebrovasular Function in Patients with MCI$133,137
K01 · FY2021 · AG · contact PI
NAD+ Therapy for Improving Memory & Cerebrovasular Function in Patients with MCI$57,637
K01 · FY2021 · AG · contact PI
NAD+ Therapy for Improving Memory & Cerebrovasular Function in Patients with MCI$133,137
K01 · FY2020 · AG · contact PI
NAD+ Therapy for Improving Memory & Cerebrovasular Function in Patients with MCI$133,137
K01 · FY2019 · AG · contact PI
NAD+ Therapy for Improving Memory & Cerebrovasular Function in Patients with MCI$133,137
K01 · FY2018 · AG · contact PI
NAD+ Therapy for Improving Memory & Cerebrovasular Function in Patients with MCI$127,288
K01 · FY2017 · AG · contact PI
NAD+ therapy for improving memory & cerebrovascular function in patients with MCI$5,849
K01 · FY2017 · AG · contact PI